ArticlePloS one2025

Feasibility trial of Darwin OncoTreat and OncoTarget precision medicine testing to improve outcomes for patients with limited metastatic disease that failed first-line systemic therapy.

Rachel Radigan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.